Hospira Recalls 19 Lots of Drugs For Visible Particle Risk

Posted on July 16, 2012

The injury risk inherent with visible particles being injected into a person’s bloodstream has led to the recall of carboplatin, methotrexate, paclitaxel, and cytarabine injections by Hospira.  The particles may potentially be found in the glass vials from 19 lots of the affected items, and these particles, once injected, could lead to symptoms that include rashes, itching, bleeding, and breathing problems.  No one has been injured as of yet, and doctors have been asked to quarantine the items.

Follow this link to learn more.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.
*Required Fields